EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (ii) All opioid outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n) Frequency unknown
Belgium37.76.212.843.3547107
Bulgaria12.84.511.970.9120624
Czech Republic50.35.79.734.257642
Denmark9.122.868.152793
Germany
Estonia2.12.46.988.646620
Ireland123.27.712.456.8314986
Greece12.610.914.861.7298217
Spain126.46.39.957.5144473927
France6.34.710.678.4112442969
Italy25.616.924.153.5210202396
Cyprus40.84.58.746.02653
Latvia31.63.113.082.3897147
Lithuania
Luxembourg37.96.924.131.0291
Hungary42.94.97.444.820312
Malta6.25.34.983.7142212
Netherlands12.52.47.677.5832609
Austria28.16.619.645.71281181
Poland42.41.11.994.55325
Portugal591.36.62.213871250
Romania15.911.07.765.342760
Slovenia25.25.911.957.04447
Slovakia23.31.39.366.12366
Finland18.55.928.047.749376
Sweden120.03.018.458.659441
United Kingdom6
Croatia84.06.43.26.448871013
Turkey
Norway13.64.513.668.2221
Total20.19.114.456.47011513105
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013